Tekturna HCT (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Tekturna HCT drug offered from Novartis Pharmaceuticals Corporation. This Renin Inhibitor [EPC],Renin Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
NON-PROPRIETARY NAME: | aliskiren hemifumarate and hydrochlorothiazide |
SUBSTANCE NAME: | ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Renin Inhibitor [EPC],Renin Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2008-08-01 |
END MARKETING DATE: | 0000-00-00 |
Tekturna HCT HUMAN PRESCRIPTION DRUG Details:
Item Description | Tekturna HCT from Novartis Pharmaceuticals Corporation |
LABELER NAME: | Novartis Pharmaceuticals Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150; 12.5(mg/1; mg/1) |
START MARKETING DATE: | 2008-08-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0078-0521_99caa324-90fc-4adc-a417-1fbfc82d3940 |
PRODUCT NDC: | 0078-0521 |
APPLICATION NUMBER: | NDA022107 |
Other ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers: